Levothyroxine Sodium Tablet
Product Images NDC 51655-714

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 714 52 Master Bottle Label Approval Rev A 05 21)

Label (51655 714 52 Master Bottle Label Approval   Rev A 05 21)
NDC 51655-714-52 e is a package of 30 Rx only Levothyroxine sodium tablets, USP, each containing 175mcg of medication. The tablets should be stored at a temperature ranging from 20-25°C, with excursions permitted between 15°-30°C. The medication should be kept out of reach of children and stored in its original container, protected from moisture and light. The product was repackaged by Northwind Pharmaceuticals from Lot 47781-665-XX in Indianapolis. The product has an expiration date of 00/00/0000 and a lot number of 0000000000.*
FDA Label Image

Levothyroxine-structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.